It's time to bring generic drug manufacturing back to the U.S. - STAT

Repatriating generic drug manufacturing would avert drug shortages, preserve the integrity of generic drugs, and create thousands of high-quality U.S. jobs.

Generic Drug - an overview

Closing the Largest Generic Drug Plant in the US Is a Sick Joke

Prescription Drug Policy, 2021 And 2022: The Year In Review, And

Challenges continue, but generics companies see a bright future

EU efforts to 'reshore' drug production trip over subsidy rules

Is the future of US pharma manufacturing domestic? - Recon Strategy

Market Exclusivity and U.S. Prescription Drugs

Generic Drugs Undergo Rigorous FDA Review

Drug Safety Fears Spur Pentagon Plan to Test Widely Used Medicines

Biden administration asserts power to seize drug patents

US Generic Drugs Market Size To Hit USD 721.54 Bn By 2032

Newsom announces $50-million contract to make California's own